GLP-1

weight loss scale weigh measure tape obesity overweight

Lilly rounds out orforglipron data ahead of obesity filings

With a complete weight loss data set in hand, Lilly is eyeing regulatory filings for orforglipron and thinks approvals could start arriving next year.

Fraiser Kansteiner Sep 17, 2025 9:00am

Lilly ends 2 midstage trials for oral GLP-1 drug naperiglipron

Sep 2, 2025 4:32am

balloon missed target pop arrows miss failure

Amylyx discontinues rare neuro program after missing ph. 2 mark

Aug 27, 2025 10:40am

Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients

Aug 26, 2025 6:45am

Response's ex-Sanofi asset hits goal in post-GLP-1 patients

Aug 13, 2025 9:14am

Yellow tape measure with a variety of weight loss medication on blue background

Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial

Aug 7, 2025 6:30am